advanced Mismatch Repair-deficient (dMMR) Endometrial Cancer
advanced Mismatch Repair-deficient (dMMR) Endometrial Cancer is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.
- Classified under
- Indicated drugs
What you can answer from here — as of October 23, 2026
2Indicated drugsWith each drug's targets and mechanismListed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for advanced Mismatch Repair-deficient (dMMR) Endometrial Cancer share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account